rs200626873

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong

The NM_017825.3(ADPRS):​c.530C>T​(p.Ser177Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000757 in 1,452,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000076 ( 0 hom. )

Consequence

ADPRS
NM_017825.3 missense

Scores

5
8
6

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 6.77

Publications

3 publications found
Variant links:
Genes affected
ADPRS (HGNC:21304): (ADP-ribosylserine hydrolase) This gene encodes a member of the ADP-ribosylglycohydrolase family. The encoded enzyme catalyzes the removal of ADP-ribose from ADP-ribosylated proteins. This enzyme localizes to the mitochondria, in addition to the nucleus and cytoplasm.[provided by RefSeq, Feb 2009]
ADPRS Gene-Disease associations (from GenCC):
  • neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.783
PP5
Variant 1-36091923-C-T is Pathogenic according to our data. Variant chr1-36091923-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 590302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADPRSNM_017825.3 linkc.530C>T p.Ser177Leu missense_variant Exon 4 of 6 ENST00000373178.5 NP_060295.1 Q9NX46
ADPRSXM_011541636.3 linkc.68C>T p.Ser23Leu missense_variant Exon 3 of 5 XP_011539938.1 B7ZAN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADPRSENST00000373178.5 linkc.530C>T p.Ser177Leu missense_variant Exon 4 of 6 1 NM_017825.3 ENSP00000362273.4 Q9NX46

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000405
AC:
1
AN:
246898
AF XY:
0.00000750
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000898
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000757
AC:
11
AN:
1452554
Hom.:
0
Cov.:
31
AF XY:
0.00000832
AC XY:
6
AN XY:
721072
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33346
American (AMR)
AF:
0.00
AC:
0
AN:
44158
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25730
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39472
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85526
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53208
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5736
European-Non Finnish (NFE)
AF:
0.00000905
AC:
10
AN:
1105402
Other (OTH)
AF:
0.0000167
AC:
1
AN:
59976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000314
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures Pathogenic:3
-
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been previously reported as a homozygous change in patients with Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome (PMID: 30100084). The c.530C>T (p.Ser177Leu) variant is located in the ADP-ribosyl-glycohydrolase, which is a known hotspot domain for pathogenic variations associated with Degenerative Pediatric Stress-Induced Epileptic Ataxia Syndrome (PMID: 30100084). The c.530C>T (p.Ser177Leu) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.0004% (1/246898) and is absent in the homozygous state, thus it is presumed to be rare. The c.530C>T (p.Ser177Leu) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.530C>T (p.Ser177Leu) variant is classified as Likely Pathogenic. -

Nov 08, 2018
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Oct 07, 2019
Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant results in the substitution of the highly-conserved serine at position 177 for a leucine. This variant localizes to coding exon 4 of the ADPRHL2 gene (6 coding exons in total; NM_017825.3), and is localized in a critical alpha-helical loop within the ADP-ribosylhydrolase domain (PMID: 30100084). In silico analysis predicts this change to be deleterious to the structure and/or function of the protein (possibly damaging by Polyphen2 and deleterious by SIFT). This variant has been observed in the Genome Aggregation Database (gnomAD) at a very low frequency (1/246,898), indicating it is not a common benign variant in the populations represented in this database. This variant has been reported in a homozygous state in two siblings with progressive weakness, seizures and deteriorating speech and motor development from a consanguineous Iranian family. Although functional studies of the variant and studies of patient cells were not performed, it was predicted to result in a loss of function (PMID: 30100084). Given this evidence, this variant is classified as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.74
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
T
Eigen
Pathogenic
0.72
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.014
T
MetaRNN
Pathogenic
0.78
D
MetaSVM
Benign
-0.82
T
MutationAssessor
Pathogenic
3.5
M
PhyloP100
6.8
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.34
Sift
Benign
0.13
T
Sift4G
Benign
0.11
T
Polyphen
0.99
D
Vest4
0.76
MutPred
0.63
Loss of disorder (P = 0.0488);
MVP
0.61
MPC
0.60
ClinPred
0.98
D
GERP RS
5.5
Varity_R
0.77
gMVP
0.77
Mutation Taster
=51/49
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200626873; hg19: chr1-36557524; COSMIC: COSV99255576; COSMIC: COSV99255576; API